MYCN and neuroblastoma: Although compared with radiomics model, nomogram did not significantly improve the prediction of MYCN amplification, they were both better than clinical model and radiomics model based on single venous phase, which demonstrated that the radiomics features are useful for predicting MYCN amplification and radiogenomics is expected to be involved in risk stratification in NB patients.